Background: Dementia is a global burden. Despite recent advances, current pharmacological treatment of dementia is unrewarding. Diabetes mellitus, dyslipidemia and hypertension are being increasingly recognized as major modifiable risk factors of dementia. Therefore, an approach towards risk factor modification and neuroprotection is needed for prevention and slowing the progression of the disease.
Objective: The objective of the study was to determine the cardiometabolic risks in patients with dementia.
Methods: This cross sectional study was conducted in the department of Neurology of Rangpur Medical College Hospital among patients with dementia between January 2016 and December 2018. 150 eligible participants of all ages with cognitive dysfunction fulfilling the selection criteria were enrolled into the study. Mini-Mental Status Examination (MMSE) was done for each subject. All patients was undergone relevant investigations. Patients having blood glucose levels of 200 mg/dl or more at 2 hours samples were termed undiagnosed DM (UDM). The outcome variables were: age, sex, hypertension, diabetes and dyslipidemia (DL).
Results: Out of 150 patients, 95 were males and 55 females with a male to female ratio 1.7:1. 37 subjects had known diabetes and 70 patients had unknown diabetes (detected after oral glucose tolerance test). An overall 71.33% subjects had diabetes, 65.33% had DL, 64.24% had HTN and 50% subjects had DM plus DL. The gender difference of DM (male vs female) were (64.89% vs 82.14%, p<0.02), DM plus DL (41.49% vs 64.29%, p<0.01) significantly higher in females, that of DL (60.63% vs 73.21% p=0.08)) and HTN (60.21% vs 71.42%, p=0.14) were also higher but the differences were not significant.
Conclusion: The prevalence of diabetes among subjects of dementia was higher than dyslipidemia and hypertension. Frequency of dementia with previously unknown diabetes outweighed known diabetes and dyslipidemia. All the metabolic abnormalities were found to be worse in females suggesting a clear sex difference in dementia.